Cargando…
Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
BACKGROUND: Surgical resection followed by chemo-radiation postpones glioblastoma (GBM) progression and extends patient survival, but these tumours eventually recur. Multimodal treatment plans combining intraoperative techniques that maximise tumour excision with therapies aiming to remodel the immu...
Autores principales: | Mączyńska, Justyna, Raes, Florian, Da Pieve, Chiara, Turnock, Stephen, Boult, Jessica K. R., Hoebart, Julia, Niedbala, Marcin, Robinson, Simon P., Harrington, Kevin J., Kaspera, Wojciech, Kramer-Marek, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780306/ https://www.ncbi.nlm.nih.gov/pubmed/35057796 http://dx.doi.org/10.1186/s12916-021-02213-z |
Ejemplares similares
-
Correction: Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022) -
Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment
por: Burley, Thomas A., et al.
Publicado: (2018) -
Thiol-Reactive PODS-Bearing Bifunctional Chelators for the Development of EGFR-Targeting [(18)F]AlF-Affibody Conjugates
por: Da Pieve, Chiara, et al.
Publicado: (2020) -
Immunomodulatory activity of IR700-labelled affibody targeting HER2
por: Mączyńska, Justyna, et al.
Publicado: (2020) -
Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations
por: Niedbała, Marcin, et al.
Publicado: (2022)